spirorenone has been researched along with ketanserin in 1 studies
*Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. [MeSH]
*Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gershon, MD; Hsiung, SC; Kirchgessner, AL; Liu, KP; Tamir, H; Yu, PY | 1 |
1 other study(ies) available for spirorenone and ketanserin
| Article | Year |
|---|---|
Identification of serotonin receptors recognized by anti-idiotypic antibodies.
Topics: Androstadienes; Animals; Antibodies, Anti-Idiotypic; Antiparkinson Agents; Brain; Carrier Proteins; Cell Line; Chromatography, Affinity; Enzyme-Linked Immunosorbent Assay; Ergolines; Fibroblasts; Fluorescent Antibody Technique; HeLa Cells; Humans; Immunohistochemistry; Iodine Radioisotopes; Iodocyanopindolol; Ketanserin; Mineralocorticoid Receptor Antagonists; Pindolol; Rabbits; Receptors, Serotonin; Serotonin; Thyroid Neoplasms; Tritium | 1991 |